133 related articles for article (PubMed ID: 24294686)
1. Curcumin and anthocyanin inhibit pepsin-mediated cell damage and carcinogenic changes in airway epithelial cells.
Samuels TL; Pearson AC; Wells CW; Stoner GD; Johnston N
Ann Otol Rhinol Laryngol; 2013 Oct; 122(10):632-41. PubMed ID: 24294686
[TBL] [Abstract][Full Text] [Related]
2. Rationale for targeting pepsin in the treatment of reflux disease.
Johnston N; Wells CW; Samuels TL; Blumin JH
Ann Otol Rhinol Laryngol; 2010 Aug; 119(8):547-58. PubMed ID: 20860281
[TBL] [Abstract][Full Text] [Related]
3. Pepsin in nonacidic refluxate can damage hypopharyngeal epithelial cells.
Johnston N; Wells CW; Samuels TL; Blumin JH
Ann Otol Rhinol Laryngol; 2009 Sep; 118(9):677-85. PubMed ID: 19810610
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of pepsin for laryngopharyngeal reflux in children with otitis media with effusion.
Abdel-aziz MM; El-Fattah AM; Abdalla AF
Int J Pediatr Otorhinolaryngol; 2013 Oct; 77(10):1765-70. PubMed ID: 24011938
[TBL] [Abstract][Full Text] [Related]
5. Receptor-mediated uptake of pepsin by laryngeal epithelial cells.
Johnston N; Wells CW; Blumin JH; Toohill RJ; Merati AL
Ann Otol Rhinol Laryngol; 2007 Dec; 116(12):934-8. PubMed ID: 18217514
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Pepsin on Human Nasal Epithelial Cells In Vitro: A Potential Mechanism for Extraesophageal Reflux Induced Chronic Rhinosinusitis.
Southwood JE; Hoekzema CR; Samuels TL; Wells C; Poetker DM; Johnston N; Loehrl TA
Ann Otol Rhinol Laryngol; 2015 Dec; 124(12):957-64. PubMed ID: 26127000
[TBL] [Abstract][Full Text] [Related]
7. Mucosal protective effects of ecabet sodium: pepsin inhibition and interaction with mucus.
Pearson JP; Roberts NB
Clin Sci (Lond); 2001 Apr; 100(4):411-7. PubMed ID: 11256980
[TBL] [Abstract][Full Text] [Related]
8. RNA Sequencing Reveals Cancer-Associated Changes in Laryngeal Cells Exposed to Non-Acid Pepsin.
Samuels TL; Zimmermann MT; Zeighami A; Demos W; Southwood JE; Blumin JH; Bock JM; Johnston N
Laryngoscope; 2021 Jan; 131(1):121-129. PubMed ID: 32202667
[TBL] [Abstract][Full Text] [Related]
9. Pepsin as a causal agent of inflammation during nonacidic reflux.
Samuels TL; Johnston N
Otolaryngol Head Neck Surg; 2009 Nov; 141(5):559-63. PubMed ID: 19861190
[TBL] [Abstract][Full Text] [Related]
10. Pepsin and carbonic anhydrase isoenzyme III as diagnostic markers for laryngopharyngeal reflux disease.
Johnston N; Knight J; Dettmar PW; Lively MO; Koufman J
Laryngoscope; 2004 Dec; 114(12):2129-34. PubMed ID: 15564833
[TBL] [Abstract][Full Text] [Related]
11. Effect of pepsin on laryngeal stress protein (Sep70, Sep53, and Hsp70) response: role in laryngopharyngeal reflux disease.
Johnston N; Dettmar PW; Lively MO; Postma GN; Belafsky PC; Birchall M; Koufman JA
Ann Otol Rhinol Laryngol; 2006 Jan; 115(1):47-58. PubMed ID: 16466100
[TBL] [Abstract][Full Text] [Related]
12. Reflux induces DNA strand breaks and expression changes of MMP1+9+14 in a human miniorgan culture model.
Sandner A; Illert J; Koitzsch S; Unverzagt S; Schön I
Exp Cell Res; 2013 Nov; 319(19):2905-15. PubMed ID: 24075964
[TBL] [Abstract][Full Text] [Related]
13. Curcumin protects against cytotoxic and inflammatory effects of quartz particles but causes oxidative DNA damage in a rat lung epithelial cell line.
Li H; van Berlo D; Shi T; Speit G; Knaapen AM; Borm PJ; Albrecht C; Schins RP
Toxicol Appl Pharmacol; 2008 Feb; 227(1):115-24. PubMed ID: 18001810
[TBL] [Abstract][Full Text] [Related]
14. In vivo investigation of acidified pepsin exposure to porcine vocal fold epithelia.
Durkes A; Sivasankar MP
Laryngoscope; 2016 Jan; 126(1):E12-7. PubMed ID: 26153224
[TBL] [Abstract][Full Text] [Related]
15. Oral and Inhaled Fosamprenavir Reverses Pepsin-Induced Damage in a Laryngopharyngeal Reflux Mouse Model.
Johnston N; Samuels TL; Goetz CJ; Arnold LA; Smith BC; Seabloom D; Wuertz B; Ondrey F; Wiedmann TS; Vuksanovic N; Silvaggi NR; MacKinnon AC; Miller J; Bock J; Blumin JH
Laryngoscope; 2023 Jan; 133 Suppl 1(Suppl 1):S1-S11. PubMed ID: 35678265
[TBL] [Abstract][Full Text] [Related]
16. Association of pepsin and DNA damage in laryngopharyngeal reflux-related vocal fold polyps.
Dai YF; Tan JJ; Deng CQ; Liu X; Lv ZH; Li XP
Am J Otolaryngol; 2020; 41(6):102681. PubMed ID: 32889371
[TBL] [Abstract][Full Text] [Related]
17. Pepsin promotes proliferation of laryngeal and pharyngeal epithelial cells.
Johnston N; Yan JC; Hoekzema CR; Samuels TL; Stoner GD; Blumin JH; Bock JM
Laryngoscope; 2012 Jun; 122(6):1317-25. PubMed ID: 22570308
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
[TBL] [Abstract][Full Text] [Related]
19. Chemopreventive anti-inflammatory activities of curcumin and other phytochemicals mediated by MAP kinase phosphatase-5 in prostate cells.
Nonn L; Duong D; Peehl DM
Carcinogenesis; 2007 Jun; 28(6):1188-96. PubMed ID: 17151092
[TBL] [Abstract][Full Text] [Related]
20. Activity/stability of human pepsin: implications for reflux attributed laryngeal disease.
Johnston N; Dettmar PW; Bishwokarma B; Lively MO; Koufman JA
Laryngoscope; 2007 Jun; 117(6):1036-9. PubMed ID: 17417109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
